和铂医药-B1月2日斥资601.34万港元回购50万股

Group 1 - The company, HAPO Pharmaceuticals-B (02142), announced a share buyback plan, spending HKD 6.0134 million to repurchase 500,000 shares at a price range of HKD 11.78 to HKD 12.12 per share [1] - Additionally, the company issued 50,000 ordinary shares under the share incentive plan approved by shareholders on November 23, 2020, to fulfill share awards [1]